Russell Alan J
Insider CIK 1853529 · EWTX Chief Scientific Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 32,500 | — | $0 | 32,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 21,094 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,273 | $43.68 | $99.3K | 31,856 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 390 | $44.46 | $17.3K | 31,466 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 30,336 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 37,367 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 3,238 | $43.68 | $141.4K | 34,129 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 32,500 | — | $0 | 32,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 21,094 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 390 | $44.46 | $17.3K | 31,466 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,273 | $43.68 | $99.3K | 31,856 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 3,238 | $43.68 | $141.4K | 34,129 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 37,367 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 30,336 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-07-01 | 2026-07-02 | 69,648 | — | $0 | 1,077,717 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-07-01 | 2026-07-02 | 130,352 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-07-01 | 2026-07-02 | 130,352 | $39.41 | $5.14M | 94,203 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-07-01 | 2026-07-02 | 130,352 | $0.45 | $58.7K | 154,907 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-07-01 | 2026-07-02 | 69,648 | $0.18 | $12.5K | 224,555 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-07-01 | 2026-07-02 | 69,648 | $39.41 | $2.74M | 24,555 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-11-12 | 2025-11-13 | 100,000 | — | $0 | 1,147,365 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-11-12 | 2025-11-13 | 100,000 | $0.18 | $18.0K | 123,400 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-11-12 | 2025-11-13 | 100,000 | $21.12 | $2.11M | 23,400 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-08-26 | 2025-08-28 | 100,000 | — | $0 | 1,247,365 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-08-26 | 2025-08-28 | 100,000 | $0.18 | $18.0K | 123,400 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-08-26 | 2025-08-28 | 100,000 | $14.60 | $1.46M | 23,400 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 28,125 | — | $0 | 28,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 17,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 168,750 | — | $0 | 168,750 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 25,307 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-08-12 | 2025-08-14 | 1,907 | $13.39 | $25.5K | 23,400 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-05-02 | 2025-05-07 | 1,551 | $16.45 | $25.5K | 18,521 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 20,072 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-03-07 | 2025-03-11 | 200 | — | $0 | 1,456,580 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-03-07 | 2025-03-11 | 200 | $30.02 | $6.0K | 14,863 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-03-07 | 2025-03-11 | 200 | $0.18 | $36 | 15,063 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-02-06 | 2025-02-07 | 1,200 | — | $0 | 1,347,565 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-02-06 | 2025-02-07 | 1,200 | $0.18 | $216 | 16,063 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-02-06 | 2025-02-07 | 1,200 | $30.13 | $36.2K | 14,863 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-02-05 | 2025-02-07 | 8,015 | — | $0 | 1,348,765 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-02-05 | 2025-02-07 | 8,015 | $30.02 | $240.6K | 14,863 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-02-05 | 2025-02-07 | 8,015 | $0.18 | $1.4K | 22,878 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-12-30 | 2024-12-31 | 100,000 | — | $0 | 1,356,780 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-12-30 | 2024-12-31 | 100,000 | $27.37 | $2.74M | 14,863 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-12-30 | 2024-12-31 | 100,000 | $0.18 | $18.0K | 114,863 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-09-20 | 2024-09-24 | 75,000 | — | $0 | 1,456,780 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 815 | $29.51 | $24.1K | 12,719 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-09-20 | 2024-09-24 | 75,000 | $0.18 | $13.5K | 87,719 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 74,185 | $28.25 | $2.10M | 13,534 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 138,750 | — | $0 | 138,750 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 23,125 | — | $0 | 23,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-05-02 | 2024-05-03 | 1,576 | $18.91 | $29.8K | 7,238 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 5,209 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 8,814 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-12-26 | 2023-12-28 | 172,585 | $9.33 | $1.61M | 3,606 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-08-17 | 2023-08-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-05-02 | 2023-05-03 | 1,602 | $8.90 | $14.3K | 176,191 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 10,417 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 177,793 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-08-08 | 2022-08-10 | 220,000 | — | $0 | 220,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-05-01 | 2022-05-03 | 15,625 | — | $0 | 15,625 | SEC↗ |
| EWTX | M Exercise deriv | 2021-11-30 | 2021-12-01 | 147,585 | — | $0 | 0 | SEC↗ |
| EWTX | M Exercise deriv | 2021-11-30 | 2021-12-01 | 25,000 | — | $0 | 130,352 | SEC↗ |
| EWTX | M Exercise | 2021-11-30 | 2021-12-01 | 25,000 | $0.45 | $11.3K | 172,585 | SEC↗ |
| EWTX | M Exercise | 2021-11-30 | 2021-12-01 | 147,585 | $0.18 | $26.6K | 147,585 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-15 | 2021-11-17 | 38 | $19.61 | $745 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-15 | 2021-11-17 | 441 | $19.07 | $8.4K | 38 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-12 | 2021-11-12 | 8,562 | $19.51 | $167.0K | 479 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-11 | 2021-11-12 | 3,681 | $20.43 | $75.2K | 9,041 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-11 | 2021-11-12 | 15,595 | $19.82 | $309.1K | 12,722 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-10 | 2021-11-12 | 11,746 | $19.70 | $231.4K | 28,897 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-10 | 2021-11-12 | 580 | $20.21 | $11.7K | 28,317 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-09 | 2021-11-12 | 12,712 | $20.30 | $258.1K | 40,643 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-09 | 2021-11-12 | 16,864 | $19.94 | $336.3K | 53,355 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-08 | 2021-11-08 | 9,017 | $20.16 | $181.8K | 70,219 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-05 | 2021-11-08 | 6 | $20.70 | $124 | 92,272 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-05 | 2021-11-08 | 13,036 | $19.62 | $255.8K | 79,236 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-04 | 2021-11-08 | 7,392 | $19.76 | $146.1K | 92,278 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-03 | 2021-11-03 | 1,119 | $19.42 | $21.7K | 99,670 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-03 | 2021-11-03 | 20,822 | $17.98 | $374.4K | 105,032 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-03 | 2021-11-03 | 4,243 | $18.84 | $79.9K | 100,789 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-02 | 2021-11-03 | 17,519 | $17.43 | $305.4K | 125,854 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-11-01 | 2021-11-03 | 469 | $18.02 | $8.5K | 143,373 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-15 | 2021-10-18 | 126 | $18.00 | $2.3K | 143,842 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-15 | 2021-10-18 | 1,307 | $18.13 | $23.7K | 143,968 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-14 | 2021-10-18 | 5,749 | $18.18 | $104.5K | 145,275 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-11 | 2021-10-13 | 1,270 | $18.02 | $22.9K | 151,024 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-08 | 2021-10-08 | 5,902 | $18.15 | $107.1K | 152,294 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-07 | 2021-10-08 | 13,018 | $18.56 | $241.6K | 158,196 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-06 | 2021-10-08 | 2,108 | $18.03 | $38.0K | 171,214 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-05 | 2021-10-05 | 5,404 | $18.26 | $98.7K | 173,322 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-04 | 2021-10-05 | 100 | $18.00 | $1.8K | 178,726 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-10-01 | 2021-10-05 | 274 | $18.00 | $4.9K | 178,826 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-29 | 2021-09-30 | 11,226 | $16.83 | $188.9K | 179,718 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-29 | 2021-09-30 | 618 | $17.47 | $10.8K | 179,100 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-28 | 2021-09-30 | 14,610 | $17.30 | $252.8K | 190,944 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-27 | 2021-09-27 | 11,594 | $17.98 | $208.5K | 205,571 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-27 | 2021-09-27 | 17 | $18.48 | $314 | 205,554 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-24 | 2021-09-27 | 20,100 | $18.16 | $365.0K | 217,165 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-23 | 2021-09-27 | 5,072 | $19.42 | $98.5K | 237,265 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2021-09-23 | 2021-09-27 | 21,763 | $18.34 | $399.1K | 242,337 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2021-08-17 | 2021-08-19 | 120,000 | — | $0 | 120,000 | SEC↗ |